A Novel Blood–Brain Barrier-Penetrating and Vascular-Targeting Chimeric Peptide Inhibits Glioma Angiogenesis

The high vascularization of glioma highlights the potential value of anti-angiogenic therapeutics for glioma treatment. Previously, we designed a novel vascular-targeting and blood–brain barrier (BBB)-penetrating peptide, TAT-AT7, by attaching the cell-penetrating peptide TAT to a vascular-targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Lu, Wang, Longkun, Zhao, Lin, Liao, Jing, Zhao, Chunqian, Xu, Xiaohan, Wang, Fengshan, Zhang, Xinke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218704/
https://www.ncbi.nlm.nih.gov/pubmed/37240099
http://dx.doi.org/10.3390/ijms24108753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218704/
https://www.ncbi.nlm.nih.gov/pubmed/37240099
http://dx.doi.org/10.3390/ijms24108753

Ejemplares similares